ZINZINO AB (PUBL.): SHARE SUBSCRIPTION DUE TO WARRANTS

In the option program, Zinzino's general meeting resolved on 31 May 2022,

50,315 B shares have been subscribed (series 2022/2027:1).

The price per share amounted to SEK 56 and in total Zinzino's equity was raised SEK 2,817,640.

In the option program, Zinzino's general meeting resolved on 31 May 2022,

15,000 B shares have been subscribed (series 2022/2027:2).

The price per share amounted to SEK 56 and in total Zinzino's equity was raised SEK 840,000.

In the option program, Zinzino's general meeting resolved on 31 May 2023,

145,000 B shares have been subscribed.

The price per share amounted to SEK 63 and in total Zinzino's equity was raised SEK 9,135,000.

The total number of B-shares increased by 210,315 to 33,772,824.

The total number of shares after the increase was 38,886,216.

The dilution amounted to 0.54 percent. Zinzino's share capital increased to SEK 3,888,621.60.

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com

Pictures for publication free of charge: marketing@zinzino.com

Certified Adviser: Tapper Partners AB

Zinzino is a global health tech company from Scandinavia, pioneering a new standard in personal health through advanced home health tests and scientifically proven nutritional supplements. Listed on the Nasdaq First North Premier Growth Market, the company’s test-based, personalized nutrition strategy empowers individuals to take charge of their long-term health with science-based insights and targeted solutions. Its third-party validated products are available through direct sales distributors in more than 100 markets worldwide. Zinzino’s headquarters are located in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.